Research graph
References from Outcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study. Local targets link to admitted publications; unresolved targets remain external evidence.
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups
10.1038/s41408-020-00340-z · 2020 · External reference
Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d’Etude des Lymphomes Folliculaires. Groupe d’Etude des Lymphomes de l’Adulte
10.1200/jco.1997.15.3.1110 · 1997 · External reference
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d’Etude des Lymphomes Folliculaires 86 Trial
1998 · External reference
Clinical Practice Guidelines in Oncology
2024 · External reference
Follicular Lymphoma International Prognostic Index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project
2009 · External reference
FLIPI24: an improved international prognostic model developed on early events in follicular lymphoma
10.1182/blood-2022-157194 · 2022 · External reference
Detection of leukemic phase in patients with follicular lymphoma at diagnosis: a rare event associated with poor prognosis
10.1182/blood.v120.21.1594.1594 · 2012 · External reference
Follicular lymphoma with leukemic phase at diagnosis: an aggressive disease. Report of seven cases and review of the literature
10.1016/j.leukres.2013.05.016 · 2013 · External reference
Clinicopathological characteristics of follicular lymphoma with peripheral blood involvement
10.3109/10428194.2014.963578 · 2015 · External reference
The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
10.1038/s41375-022-01620-2 · 2022 · External reference
Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the national LymphoCare study
10.1200/jco.2014.59.7534 · 2015 · External reference
An application of changepoint methods in studying the effect of age on survival in breast cancer
10.1016/s0167-9473(98)00096-6 · 1999 · External reference
Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients
10.1002/hon.3278 · 2024 · External reference
